ATRA   $17.995  0.98% Market Closed

Atara Biotherapeutics, Inc.
Last Events:

2023-08-09 Trend pattern changed from сужающийся канал to канал.

2023-08-09 Signal in RSI changed from bullish recovery to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: exit from the overbought zone.

2023-08-06 Trend Power changed from slow to medium strength.

2023-08-05 Signal in Stochastic changed from bullish to bullish weakening. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: main and signal line crossing.

2023-08-05 Signal in RSI changed from bullish weakening to bullish recovery. RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-04 Trend pattern changed from нисходящий треугольник to сужающийся канал.

2023-08-04 Trend Power changed from medium strength to slow.

2023-08-03 Signal in RSI changed from bullish to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: exit from the overbought zone.


Current temperature: 8.19
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 3
Target Price Mean 17.00
Mean unverified/preliminary 17.00 / 17.00
Target Price Low / High 16.00 / 18.00
Median / STD DEV 17.00 / 1.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell ActivelyBuy Sell
macd None None None
stoch None None None
ma20 None Sell Sell
ma50 None None None
ma100 Sell Sell None
Candlestick PatternDec. 2, 2025 Bearish Ladder - pattern is a made up of five candlesticks. Pattern appears on a uptrend. Three strong white candlesticks follows by the fourth white candlestick closes also higher but has a long lower shadow. The fifth day is a strong black with an open below the previous day’s body. Considered to be a bearish reversal pattern.
ISIN US0465132068
ceo Dr. Anhco Nguyen Ph.D.
Website https://www.atarabio.com
Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the United States and the United Kingdom. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as nasopharyngeal carcinoma. Its CAR T immunotherapy pipeline products include ATA3219, currently in Phase 1 trials, as well as ATA3431, under preclinical trials for the treatment of B-cell malignancies and autoimmune diseases; and ATA188 that is in Phase 2 clinical trials to treat multiple sclerosis. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.